James C. Chapman

Partner

Office:

Palo Alto

Practice Groups and Client Sectors:

Corporate, International, Technology

Areas of Focus:

International Transactions, Life Sciences, Mergers & Acquisitions, Commercial Transactions, Emerging Companies, Partnerships and Other Joint Ventures, Securities Compliance and Offerings, Venture Capital & Angel Financing
James C. Chapman

Education

The Catholic University of America

B.A. International Relations; B.A. Spanish

Santa Clara University

J.D.

Santa Clara University

M.B.A.

Bars & Courts

  • California

Languages

  • Mandarin
  • Spanish

Professional Experience

Mr. Chapman focuses his practice on securities law, venture capital, mergers and acquisitions, and international business transactions. He counsels publicly traded and privately held clients on public offerings, private placements, debt financings, venture capital transactions, mergers and acquisitions, and related transactions. Mr. Chapman also represents venture capital firms, angels, and private equity groups in their investments. With 30 years of experience in corporate and securities law, he has represented clients in over 300 mergers, acquisitions, and financing transactions.

Mr. Chapman has counseled clients ranging from media to pharmaceutical companies on numerous China-United States transactions. His international transactions work includes assisting Chinese companies in both investing and raising capital in the United States. Mr. Chapman also assists U.S. firms in investing and operating in China and has been involved in negotiating resolutions to some of the most high-profile disputes involving US companies operating in China.


REPRESENTATIVE MATTERS

MERGERS & ACQUISITIONS:

  • Represented Financial Navigator, Inc. in connection the sale of the Company to Asset Vantage
  • Represented A-1 Machine Manufacturing, Incorporated in the sale of a 49% interest to Graycliff Partners for $20 million
  • Represented Liquid Agency, Inc. in the repurchase of the shares of a holder of 45% of the company
  • Represented United Genetics in its sale to Kagome
  • Represented medical device manufacturer in connection with the sale of the company
  • Represented PC Board specialty manufacturer in connection with the sale of the company
  • Represented advertising agency in connection with the acquisition of three companies
  • Represented investment banker in connection with the $750 million sale of a medical device company
  • Represented Pigeon Point, Inc. in connection with its sale to Actel
  • Represented Wrapsidy LLC in connection with the sale of the company to SQAD, Inc.
  • Represented Bellatore, LLC in connection with the acquisition of Capital Asset Management, Advisory Partners and the financial advisory division of Nationwide Insurance
  • Represented Business Finance Capital Corporation in connection with its merger with First Community Bank

VENTURE FINANCINGS —INVESTOR REPRESENTATION:

  • Represented a Chinese publicly traded pharmaceutical company in connection with its investment in a US privately held life science company.
  • Represented Konica-Minolta  in connection with its investment in Knightscope
  • Represented Savitr Capital in connection with the purchase of shares of Series G Preferred Stock of Aseko, Inc. in the amount of $5 million
  • Represented Savitr Capital in connection with the purchase of shares of Series A Preferred Stock of NeoSeq, Inc. in the amount of $2.5 million
  • Represented Savitr Capital in connection with the purchase of a Convertible Promissory Note from NVS Technologies, Inc.
  • Represented Shamrock Ionetix in connection with the purchase of shares of Series E Preferred Stock of Ionetix, Inc. in the amount of $6 million
  • Represented Tsuha Capital in connection with its purchase of shares of Series D Preferred Stock of Fuhu, Inc.
  • Represented Intel Capital in connection with its purchase of shares of Series A Preferred Stock on Maana
  • Represented Intel Capital in connection with purchase of shares of Series AA Stock from HealthiNation
  • Represented Citrix Start-up Accelerator in connection with the seed financing of Zettar, Inc.
  • Represented Citrix Start-up Accelerator in connection with the seed financing of Apakau, Inc.
  • Represented Savitr Capital and its affiliate in connection with the purchase of shares of Series D Preferred Stock of Curaseal, Inc.
  • Represented Savitr Capital and its affiliate in connection with the purchase of shares of Series E Preferred Stock of Guided Delivery Systems, Inc.
  • Represented Savitr Capital and its affiliate in connection with the purchase of shares of Druggability Technologies Limited
  • Represented the Band of Angels in connection with its purchase of shares of Series A Preferred in CargoChief, Inc.
  • Represented Whitman Capital in connection with its investment in Coupang, Inc.
  • Represented the Band of Angels in connection with four of its investment transactions in 2011 and five of its investments in 2012

VENTURE FINANCINGS—COMPANY REPRESENTATION:

  • Represented iCharts, Inc. in connection with the sale of its Series B3 Preferred Stock
  • Represented RoboSig in connection with its seed financing
  • Represented Global Innovations, Inc. in connection with the sale of its Series A Preferred Stock
  • Represented Ghangor Cloud, Inc. in connection with the sale of its Series A Preferred Stock
  • Represented Washsense, Inc. in connection with its seed financing
  • Represented iCharts, Inc. in connection with the sale of Series B2 Preferred Stock in the amount of $5.5 million
  • Represented Ink Labs, Inc. in connection with the sale of Convertible Promissory Notes in the amount of $2.1 million
  • Represented Indus Holding Company in connection with the sale of Series A2 Preferred Stock in the amount of $2.1 million
  • Represented Wisenstech Ltd in connection with the sale of Series A Preferred Stock in the amount of $5 million
  • Represented iCharts, Inc in connection with the sale of its Series B Preferred Stock to Software AG
  • Represented Senodia Technologies, Inc. in connection with the sale of its Series C Preferred Stock to DFJ DragonFund
  • Represented iHookup Social, Inc. in connection with the equity line of credit issued by Beaufort Capital Partners
  • Represented Cubicon, Inc. in connection with its seed financing
  • Represented Tiara Pharmaceutical in connection with its seed financing
  • Represented Ink Labs in connection with its seed financing by Crescendo Venture Management
  • Represented iCharts, Inc. in connection with its seed and Series A Preferred Financings
  • Represented Senodia Technologies, Inc. in connection with its Series B Preferred Financing
  • Represented Scent Sciences Corporation in connection with its Series A Preferred Financing
  • Represented FiveRun, Inc. in connection with its seed financing
  • Represented Zippi Networks in connection with an $11 million equity line of credit with Palm Valley Capital
  • Represented Bellatore, Inc. in connection with its $11 million Series A financing
  • Represented Fat Spaniel Technologies, Inc. in connection with its Series A Preferred and bridge financings

FUND FORMATION:

  • Represented Menlo Asset Backed Partners II in connection with its investment fund formation
  • Represented China Start-up Republic in connection with its investment fund formation
  • Represented the Band of Angels Acorn Fund I in connection with its investment fund formation
  • Represented Menlo Equities and its investment funds in connection with Dodd-Frank Act compliance
  • Represented Austin Glen Core LLC in connection with its formation and structure of its real estate acquisition fund
  • Represented TAS Commerce Fund I in connection with its formation and structure of its Asia investment fund
  • Represented Northwest Fund I in connection with the sale of Series C membership units
  • Represented Northwest Fund I in connection with the sale of Series A and B membership units

CHINA:

  • Represented 4C Air, Inc. in connection with the formation of a joint venture in China and transfer of technology
  • Represented a Chinese publicly traded pharmaceutical company in connection with its investment in a US privately held life science company.
  • Represented multibillion-dollar technology company in connection with the NDRC anti-monopoly investigation. The investigation was terminated.
  • Represent US publicly traded pharmaceutical company in connection with its China operations
  • Represented large multibillion-dollar US semiconductor company in connection with its China transactions
  • Represented large US technology company in connection with the sale of a patent portfolio for mobile chipsets to Chinese company
  • Represented large US technology company in connection with the license of certain semiconductor patents to a Chinese company.
  • Represented U.S. Fortune 50 company in connection with investment in and technology transfer to company in China
  • Represented Chinese incubator in connection with its legal matters in China
  • Represented life science SAAS company in connection with the license and distribution of its services in China
  • Represented clean technology company in connection with a joint venture and license of technology to Chinese partner
  • Represented US pharma company in connection with research and development agreement with Chinese company
  • Represented US medical products manufacturer in connection with its joint venture in China
  • Represented Sierra Asia Partners in connection with the reorganization of its US and China operations
  • Represented SST Communications (Singapore), as co-counsel with King & Wood, in a joint-venture
  • Represented Tiens BioTech Group, USA, in its merger with Tianshi International Holdings Group of China
  • Represented China Agritech (PRC), along with co-counsel King & Wood in PRC, in its US public offering

AWARDS AND AFFILIATIONS

  • China Investment Attorney of the Year – California 2017 Lawyer International
  • China Investment Attorney of the Year 2017 Worldwide Financial Advisor
  • Lawyer of Distinction (Top 10% of Lawyers in USA) 2017  
  • Best M&A Attorney – California 2016  AI Global Media
  • China Investment Attorney of the Year 2016,   Worldwide Finanical Advisor
  • China Investment Attorney of the Year 2016,  Corporate Live Wire
  • China Investment Attorney of the Year 2016,  Finance Monthly
  • China Investment Attorney of the Year 2016,  Lawyer International
  • Best for Public Offerings and Private Placements, Oct 2015  Corporate America M&A Awards
  • China Investment Attorney of the Year in California 2015, Oct 2015  Global Law Experts
  • Lawyer of Distinction - Corporate Transactions, Oct 2015 Lawyers of Distinction
  • China Investment Attorney of the Year USA 2015, Apr 2015  Finance Monthly
  • China Investment Attorney of the Year – California 2015  Corporate INTL Magazine Legal
  • China Investment Attorney of the Year, Finance Monthly (2015)
  • China Investment Attorney of the Year in California, Corporate INTL Magazine (2014)
  • Rated BV® Distinguished™, Martindale-Hubbell’s Peer Review Rating System
  • Northern California Super Lawyers® (2004–2008, 2012)
  • Top 25 Clean Tech Lawyers in California, Daily Journal (2011)
  • Legal 500, Mergers & Acquisitions (2010)
  • Silicon Valley’s Top Attorneys, San Jose Magazine (2003–2007)

Publications

  • Trade Secret Protection in China: A Perspective from China and Hong Kong, publication description Association of Corporate Counsel. Jan. 2013
  • Corporate Law Insights: Top Corporate Lawyers Share What They Know Best, Chapter - "Mergers & Acquisitions-What Every CEO Should Know", publication description ExecuSense. Oct. 2012  
  • Joint Ventures in China: What Every CEO Should Know, publication description VC Experts. Sep 2012  
  • 8 Trends in Venture Capital, publication description Law360. June 4, 2012  
  • Cleantech Patents and Investments: What to Expect in 2012, publication description Law360. Feb. 29, 2012
  • Company for Sale: Five Common mistakes to Avoid, publication description Daily Journal. Nov. 10, 2011  
  • Mergers and Acquisitions in China: Part Two - Anatomy of a Deal in the Middle Kingdom, publication description Corporate Finance Review. Nov. 2011
  • Clean Technology Innovation in China, publication description Top Capital Magazine. Oct. 2011
  • A Brave New World: Technology Transfer to China, publication description The Licensing Law Journal. Sep. 2011  
  • Mergers and Acquisitions in China: Anatomy of a Deal--Part 1, publication description Corporate Finance Review. Sep. 2011
  • "Jiao Pengyou"-A Guide for Successful Business Relationships in China, publication description American Management Association. Mar. 5, 2011
  • Mergers and Acquisitions in China; Trends and Challenges in the Middle Kingdom, publication description Westlaw Business Currents. Feb. 17, 2011  
  • Mergers & Acquisitions in China: Current Trends, and Challenges in the Middle Kingdom, publication description The Association for Corporate Growth. Jan. 15, 2011
  • M&A in China: Ten Strategies for Successful Cross-Border Transactions, publication description Asian Counsel. Sep. 1, 2008
  • In the Eye of a Hurricane - Duties of Directors in a Turbulent Environment, publication description Software Developers Forum. Aug. 15, 2008
  • The Road to China: Ten Key Lessons for Doing Business in China, publication description The Licensing Law Journal. Aug. 1, 2008
  • China IPO's: An Era of Transition, publication description Asia Counsel. May 15, 2008
  • Trends in Mergers & Acquisitions, publication description Band of Angels Newsletter. Mar. 15, 2008  
  • Trends in IPO's, publication description Corporate Counselor. Sep. 15, 2007
  • Tumultuous Times: Trends in Venture Capital, publication description Daily Journal.